HIV vaccine (Institute of Human Virology/Profectus Biosciences)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHIV vaccine (Institute of Human Virology/Profectus Biosciences)
Drug Alias NameFLSC vaccineFull-length single chain vaccineAIM Therapyanti-HIV antibodiesIHV 001 +[6] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesThailand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAuro Vaccines Llc
China Registration ClassN/A

Develop Information

Active CompaniesCase Western Reserve UniversityDuke UniversityUniversity Of Maryland, Baltimore
Inactive CompaniesAuro Vaccines LlcNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A